Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Early-Stage Triple-Negative Breast Cancer: a Phase 2 Adaptive Trial
Iris Nederlof,Olga I Isaeva, Manon de Graaf, Robbert C A M Gielen,Noor A M Bakker, Adrianne L Rolfes,Hannah Garner,Bram Boeckx,Joleen J H Traets,Ingrid A M Mandjes,Michiel de Maaker,Thomas van Brussel,Maksim Chelushkin,Elisa Champanhet,Marta Lopez-Yurda,Koen van de Vijver,José G van den Berg,Ingrid Hofland, Natasja Klioueva,Ritse M Mann,Claudette E Loo,Frederieke H van Duijnhoven, Victoria Skinner, Sylvia Luykx,Emile Kerver,Ekaterina Kalashnikova,Marloes G J van Dongen,Gabe S Sonke,Sabine C Linn,Christian U Blank,Karin E de Visser, Roberto Salgado,Lodewyk F A Wessels,Caroline A Drukker,Ton N Schumacher,Hugo M Horlings,Diether Lambrechts,Marleen Kok Nature medicine（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper